Imaging Alzheimer Pathology in Late-Life Depression With PET and Pittsburgh Compound-B
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
There is increasing evidence for an empiric link between late-life depression and Alzheimer disease (AD). The neuropathology of AD, previously only confirmed at autopsy, may now be detectable in vivo using selective imaging ligands for beta-amyloid. Positron emission tomography (PET) with [11C] 6-OH-BTA-1 [Pittsburgh Compound-B (PiB)] has shown high tracer retention in cortical areas in patients with clinical diagnoses of probable AD and low retention in age-matched controls. We also previously reported variable PiB retention in patients with mild cognitive impairment (MCI). In this study, we used PiB-PET to evaluate whether amyloid is present in elders with treated major depression, many of whom have persistent cognitive impairment. We evaluated 9 subjects with remitted major depression [3M: 6F, mean (SD) age=71.8(5.7) y]. Seven of the 9 depressed subjects also met criteria for the diagnosis of MCI. PiB-PET data from healthy elders [n=8; mean (SD) age=71.5(3.0) y] were used for comparison. PET was acquired with arterial sampling and PiB retention was quantified using magnetic resonance imaging-guided cortical regions and graphical analysis of time-activity data; arterial line failure led to exclusion of 1 depressed subject. The data demonstrated variably elevated PiB retention. PiB retention in the 2 depressed subjects with normal cognitive ability was in the range of nondepressed cognitively normal subjects. PiB retention in 3 of the 6 depressed subjects with MCI fell in the range of subjects with AD. PiB retention in the remaining 3 depressed subjects with cooccurring MCI was variable and generally was intermediate to the other subjects. Our findings are consistent with and supportive of the hypothesis that depression may herald the development of AD in some individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · cited 8×
“Reported rates of dementia among late-life depression patients vary considerably, from 10% to nearly 90%.1–3 A meta-analysis of the results from 7 case-control and 6 prospective studies suggests that depression in late life approximately doubles an individual’s dementia risk.4 A more recent meta-analysis performed by…”
BackgroundInfluentialMirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Self-citationDynamic magnetic resonance imaging of human brain activity during primary sensory stimulation.
Kwong, K. K., Belliveau, J. W., Chesler, D. A., Goldberg, I. E., Weisskoff, R. M., Poncelet, B. P., Kennedy, D. N., Hoppel, B. E., Cohen, M. S., & Turner, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5675 · Cited by 4,212
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
A simple objective technique for measuring flexibility in thinking
Berg, E. A. (1948) · The Journal of General Psychology · doi:10.1080/00221309.1948.9918159 · Cited by 2,255
Lyketsos, C. G., Lopez, O., Jones, B., Fitzpatrick, A. L., Breitner, J., & DeKosky, S. (2002) · JAMA · doi:10.1001/jama.288.12.1475 · Cited by 2,049 · cited 2×
“Cardiovascular Health Study who had mild cognitive impairment (MCI) and 32% of those with dementia also exhibited depressive symptoms.(12) The risk of dementia in patients with MCI also seems to be greater in those individuals who also exhibit neuropsychiatric symptoms, particularly depression.”
BackgroundSelf-citationVitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844 · cited 1×
“The Alzheimer’s Disease Cooperative Study Group reported an annual rate of progression to AD of 16% among 769 MCI subjects followed over 3 years.(63) Approximately 50% of individuals with MCI progress to develop AD over a 5-year period, indicating that a diagnosis of MCI alone is not a sufficient predictor of dementia…”
Background
Cited by
Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future
Geda, Y. E., Schneider, L. S., Gitlin, L. N., Miller, D. S., Smith, G. S., Bell, J., Evans, J., Lee, M., Porsteinsson, A., Lanctôt, K. L., et al. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.12.001 · Cited by 378
“[61] Butters MA, Klunk WE, Mathis CA, Price JC, Ziolko SK, Hoge JA, et al.”
BackgroundMethodBai, F., Shu, N., Yuan, Y., Shi, Y., Yu, H., Wu, D., Wang, J., Xia, M., He, Y., & Zhang, Z. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5061-11.2012 · Cited by 299
Naismith, S. L., Norrie, L. M., Mowszowski, L., & Hickie, I. B. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.05.009 · Cited by 270
Neuropathological correlates of late-life depression in older people
Tsopelas, C., Stewart, R., Savva, G. M., Brayne, C., Ince, P., Thomas, A., & Matthews, F. E. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.078816 · Cited by 182
Walker, J. G., Batterham, P. J., Mackinnon, A. J., Jorm, A. F., Hickie, I., Fenech, M., Kljakovic, M., Crisp, D., & Christensen, H. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.007799 · Cited by 165
“The latter mechanism may be plausible because a recent study showed a higher retention of Pittsburgh Compound-B, a selective imaging ligand for b-amyloid in the brain, in depressive patients compared with controls (48).”
The complex relationship between depression and dementia
Varghese, M., & Muliyala, K. (2010) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.74248 · Cited by 119
“[53] Approximately, one-half of nine remitted patients with LOD demonstrated PiB retention indicative of brain β-amyloid accumulation in cortical areas in a pattern characteristic of early AD in a PET scan study.[54] The gray matter changes in LOD involve smaller volumes of several frontal, temporal areas, cingulum, p…”
BackgroundDiniz, B. S., Sibille, E., Ding, Y., Tseng, G., Aizenstein, H. J., Lotrich, F., Becker, J. T., Lopez, O. L., Lotze, M. T., Klunk, W. E., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.76 · Cited by 116
Self-citationDepressive symptoms accelerate cognitive decline in amyloid-positive MCI patients
Initiative, F. T. A. D. N., Brendel, M., Pogarell, O., Xiong, G., Delker, A., Bartenstein, P., & Rominger, A. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2975-4 · Cited by 94
“Previous [(11)C]PiB PET findings in a small group of patients have also provided evidence that amyloid load is elevated in late-life depressed MCI subjects [8].”
De Winter, F.-L., Emsell, L., Bouckaert, F., Claes, L., Jain, S., Farrar, G., Billiet, T., Evers, S., Van den Stock, J., Sienaert, P., et al. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16030319 · Cited by 80
Cognitive debt and Alzheimer’s disease
Marchant, N. L., & Howard, R. J. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-141515 · Cited by 68
“The two existing neuroimaging studies of A also report conflicting results [178, 179], and a study using a combined measure of A and tau binding showed an association with depression and anxiety [180].”
ResultLack of association between prior depressive episodes and cerebral [11C]PiB binding
Madsen, K., Hasselbalch, B. J., Frederiksen, K. S., Haahr, M. E., Gade, A., Law, I., Price, J. C., Knudsen, G. M., Kessing, L. V., & Hasselbalch, S. G. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.11.021 · Cited by 66
“Butters and coworkers analyzed [C]PiB PET scans in 8 elderly subjects with remitted late-life depression of which 6 also had MCI (Butters et al., 2008).”
BackgroundSelf-citationGoveas, J. S., Hogan, P. E., Kotchen, J. M., Smoller, J. W., Denburg, N. L., Manson, J. E., Tummala, A., Mysiw, W. J., Ockene, J. K., Woods, N. F., et al. (2012) · International Psychogeriatrics · doi:10.1017/s1041610211002778 · Cited by 54
Clinicopathological correlates of depression in early Alzheimer's disease in the NACC
McCutcheon, S. T., Han, D., Troncoso, J., Koliatsos, V. E., Albert, M., Lyketsos, C. G., & Leoutsakos, J. S. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4435 · Cited by 29
“Using Pittsburgh Compound B positron emission tomography, Butters and colleagues demonstrated that approximately one-half of individuals with MCI and remitted major depression had a retention pattern similar to early AD (Butters et al., 2008).”
MethodKitzlerová, E., Fišar, Z., Lelková, P., Jirák, R., Zvěřová, M., Hroudová, J., Manukyan, A., Martásek, P., & Raboch, J. (2018) · Medical Science Monitor · doi:10.12659/msm.907202 · Cited by 21
“Preliminary evidence indicate that regionspecific Ab deposition may be present in some MDD patients, especially in those with treatment resistance, and their depressive symptoms may represent prodromal manifestations of AD [5,6].”
Background
Metadata
- Authors
- Butters, M. A., Klunk, W. E., Mathis, C. A., Price, J. C., Ziolko, S. K., Hoge, J. A., Tsopelas, N. D., Lopresti, B. J., Reynolds, C. F., DeKosky, S. T., & Meltzer, C. C.
- Venue
- Alzheimer Disease & Associated Disorders
- Published
- 2008-07
- Volume
- 22
- Issue
- 3
- Pages
- 261-268
- ISSN
- 0893-0341 (ISSN-L)
- OpenAlex
- W1981648918
- Cited by
- 139
- References
- 21
- FWCI
- 6.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.